TXG$70.1114.03%-11.44
After Hours: 69.85-0.26 -0.37%
10 X Genomics Inc (TXG)
Date: 2026-10-30 16:00O: 73.65H: 75.79L: 67.42C: 70.11Vol: 5.215M
10 X Genomics Inc stock is traded at $70.11, with a volume of 5,214,945. It is down -14.03% in the last 24 hours and down -22.41% over the past month. 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Previous Close:
$81.55
Open:
$73.65
24h Volume:
5,214,945
Relative Volume:
1.70
Market Cap:
$9.13B
Revenue:
$638.78M
Net Income/Loss:
-$22.66M
P/E Ratio:
-
EPS:
-$0.1744
Net Cash Flow:
$122.18M
1W Performance:
-2.01%
1M Performance:
-22.41%
6M Performance:
+217.96%
1Y Performance:
+463.59%
1-Day Range:
$67.42$75.79
1-Week Range:
$67.42$87.82
52-Week Range:
$12.34$102.81
10 X Genomics Inc Stock (TXG) Company Profile
Name
10 X Genomics IncSector
HealthcareIndustry
Medical DevicesPhone
(925) 401-7300Address
6230 STONERIDGE MALL ROAD, PLEASANTON, CA, USACompare TXG vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXG 10 X Genomics Inc | $70.11 | $9.13B | $638.78M | -$22.66M | $122.18M | -$0.1744 |
 ABT Abbott Laboratories | $106.20 | $183.77B | $46.59B | $5.41B | $7.38B | $3.09 |
 MDT Medtronic Plc | $96.54 | $123.49B | $36.36B | $4.84B | $5.43B | $3.73 |
 SYK Stryker Corp | $291.86 | $111.95B | $25.27B | $3.34B | $4.57B | $8.63 |
 BSX Boston Scientific Corp | $41.98 | $60.84B | $20.62B | $3.56B | $3.48B | $2.38 |
 EW Edwards Lifesciences Corp | $92.01 | $53.03B | $6.30B | $1.07B | $1.09B | $1.84 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
10 X Genomics Inc Stock (TXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
10 X Genomics Inc Stock (TXG) Insider Trading
- Saxonov SergeSep 22 '26Chief Executive Officer
- Transaction
- Sale
- Cost
- $81.22
- #Shares
- 25,000
- Value ($)
- 2,030,562
- #Shares Total
- 1,050,249
- Shehnaaz SulimanSep 22 '26Affiliate
- Transaction
- Proposed Sale
- Cost
- $79.10
- #Shares
- 5,723
- Value ($)
- 452,689
- #Shares Total
- 0
- Taich AdamSep 09 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $64.57
- #Shares
- 46,388
- Value ($)
- 2,995,470
- #Shares Total
- 316,344
- ADAM TAICHSep 09 '26Officer
- Transaction
- Proposed Sale
- Cost
- $64.57
- #Shares
- 46,388
- Value ($)
- 2,995,470
- #Shares Total
- 0
- STUELPNAGEL JOHN RSep 03 '26Director
- Transaction
- Sale
- Cost
- $61.75
- #Shares
- 20,000
- Value ($)
- 1,235,072
- #Shares Total
- 328,436
- STUELPNAGEL JOHN RSep 03 '26Director
- Transaction
- Proposed Sale
- Cost
- $61.75
- #Shares
- 20,000
- Value ($)
- 1,235,046
- #Shares Total
- 0
- Serge SaxonovAug 26 '26Director, CEO
- Transaction
- Proposed Sale
- Cost
- $62.18
- #Shares
- 35,486
- Value ($)
- 2,206,654
- #Shares Total
- 0
- Saxonov SergeAug 26 '26Chief Executive Officer
- Transaction
- Sale
- Cost
- $63.69
- #Shares
- 10,486
- Value ($)
- 667,901
- #Shares Total
- 1,075,349
- SULIMAN SHEHNAAZAug 24 '26Director
- Transaction
- Sale
- Cost
- $63.65
- #Shares
- 2,207
- Value ($)
- 140,478
- #Shares Total
- 29,515
- Taich AdamAug 24 '26Officer
- Transaction
- Proposed Sale
- Cost
- $65.12
- #Shares
- 16,614
- Value ($)
- 1,081,904
- #Shares Total
- 0
